Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886712 · ClinicalTrials.gov registry record · NA
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
A NA study of Overdose and Implementation as Usual, sponsored by RTI International.
- Active
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT05886712 is a NA study of Overdose and Implementation as Usual that is active but no longer recruiting, run by RTI International. The registered enrollment target is 31 participants, below the 263-participant average among 13 other Overdose trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05886712, a NA study of Overdose and Implementation as Usual, is active but no longer recruiting, sponsored by RTI International.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the effectiveness of a multi-faceted implementation strategy, the Systems Analysis and Improvement Approach for Naloxone (SAIA-N), in syringe service programs (SSPs). The main questions it aims to answer are: * Does SAIA-N improve naloxone distribution (number of doses, number of people receiving naloxone) compared to implementation as usual (IAU)? * What are the costs associated with SAIA-N and how cost-effective is the strategy? SSPs randomized to the SAIA-N arm will participate in the strategy for a period of 12-months during which they will meet 1-2 times each month with a SAIA coach who will assist the SSP in optimizing their naloxone distribution. Researchers will compare SAIA-N to IAU to see if naloxone distribution and costs and cost-effectiveness differ by group.
Conditions Studied
Interventions
- OTHER Naloxone
- OTHER Usual intervention
Study Locations (1)
California
- RTI International - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05886712
The ClinicalTrials.gov registry entry for NCT05886712 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 13 other Overdose trials with a reported enrollment target (88% lower). The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Overdose appearing as the primary indexed condition, and to 2 interventions - of which Naloxone is the first listed.
NCT05886712 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05886712 about?
NCT05886712 is a clinical study titled "Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)". The goal of this clinical trial is to compare the effectiveness of a multi-faceted implementation strategy, the Systems Analysis and Improvement Approach for Naloxone (SAIA-N), in syringe service programs (SSPs). The main questions it aims to answer are: * Does SAIA-N improve naloxone distribution ...
What is the current status of trial NCT05886712?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2023-07-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05886712 study?
This clinical trial studies the following conditions: Overdose, Implementation as Usual.
What interventions are being tested in trial NCT05886712?
The interventions under investigation include: Naloxone (OTHER), Usual intervention (OTHER).
Who is sponsoring clinical trial NCT05886712?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05886712 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
RECRUITING · NA
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
ACTIVE NOT RECRUITING · NA
-
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Medication Health Center to Promote Opioid Safety
ACTIVE NOT RECRUITING · NA
-
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.